product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Rho-GTPase Antibody Sampler Kit
catalog :
9968
conjugate :
nonconjugated
reactivity :
human
application :
western blot
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig 5o
Yin H, Wang J, Li H, Yu Y, Wang X, Lu L, et al. Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness. Nat Commun. 2021;12:4230 pubmed publisher
  • western blot; human; loading ...; fig 5b
Al Thawadi H, Abu Kaoud N, Al Farsi H, Hoarau Véchot J, Rafii S, Rafii A, et al. VE-cadherin cleavage by ovarian cancer microparticles induces β-catenin phosphorylation in endothelial cells. Oncotarget. 2016;7:5289-305 pubmed publisher
Krisko J, Martinez Torres F, Foster J, Garcia J. HIV restriction by APOBEC3 in humanized mice. PLoS Pathog. 2013;9:e1003242 pubmed publisher
Vatolin S, Khan S, Reu F. Direct chromatin PCR (DC-PCR): hypotonic conditions allow differentiation of chromatin states during thermal cycling. PLoS ONE. 2012;7:e44690 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.